PhRMA board reschedules meeting with McClellan
FDA Commissioner McClellan is tentatively scheduled to meet with the Pharmaceutical Research & Manufacturers of America board Oct. 16. He was scheduled to attend the board's Sept. 18 meeting, but PhRMA held a teleconference instead because of Hurricane Isabel. McClellan's Sept. 18 meeting with Biotechnology Industry Organization executive committee went forward as planned...
You may also be interested in...
During oral argument in the Arthrex case, several justices seemed to agree with the Federal Circuit that PTAB judges should have been appointed by the president. They could opt to get around the problem by enabling the PTO director to review all panel decisions.
House Bill 2325, on a fast track in West Virginia, would bar the state’s Board of Barbers and Cosmetologists from regulating unlicensed individuals’ use or application of “generally available” cosmetic products for paying clients. PGA’s government affairs team provides detail.
This time we touch on Pfizer’s R&D plans, real-world evidence for coronavirus vaccines, a new approval in lung cancer, challenges for Galapagos, and Takeda's pipeline story.